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Morgantown, West Virginia 26506 and the 储Institute for Neuroscience, Northwestern University, Chicago, Illinois 60611

The molecular basis of selectivity in G-protein receptor
coupling has been explored by comparing the abilities of
G-protein heterotrimers containing chimeric G␣ subunits, comprised of various regions of Gi1␣, Gt␣, and Gq␣,
to stabilize the high affinity agonist binding state of serotonin, adenosine, and muscarinic receptors. The data indicate that multiple and distinct determinants of selectivity exist for individual receptors. While the A1 adenosine
receptor does not distinguish between Gi1␣ and Gt␣ sequences, the 5-HT1A and 5-HT1B serotonin and M2 muscarinic receptors can couple with Gi1 but not Gt. It is possible to distinguish domains that eliminate coupling and
are defined as “critical,” from those that impair coupling
and are defined as “important.” Domains within the N
terminus, ␣4-helix, and ␣4-helix-␣4/␤6-loop of Gi1␣ are involved in 5-HT and M2 receptor interactions. Chimeric
Gi1␣/Gq␣ subunits verify the critical role of the G␣ C terminus in receptor coupling, however, the individual receptors differ in the C-terminal amino acids required for
coupling. Furthermore, the EC50 for interactions with Gi1
differ among the individual receptors. These results suggest that coupling selectivity ultimately involves subtle
and cooperative interactions among various domains on
both the G-protein and the associated receptor as well as
the G-protein concentration.

A large number of diverse seven transmembrane-spanning
cell surface receptors mediate signaling to a variety of intracellular effectors by coupling to the heterotrimeric guanine
nucleotide-binding regulatory proteins (G-proteins)1 (1). The
mechanisms responsible for selectivity in G-protein-mediated
signaling pathways are not fully understood (2, 3). Although it
is known that at the molecular level the selectivity in G-protein
receptor coupling is determined by amino acid sequences of
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1
The abbreviations used are: G-proteins, heterotrimeric guanine
nucleotide-binding regulatory proteins; GPCRs, G-protein-coupled receptors; GTP␥S, guanosine 5⬘-3-O-(thio)triphosphate; OXO-M, oxotremorine-M; 5-HT, hydroxytryptamine; CCPA, chloro-N6-cyclopentyladenosine, R-PIA, R-phenylisopropyl adenosine; CHAPS, 3-[(3cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.

both receptor and G-protein, the individual amino acids involved in this selective recognition have not been completely
identified. Different receptor systems and different methodologies indicate that the G␣ subunit C terminus and ␣5-helix
(4 –7), N terminus, and ␣N-helix (4, 8 –10), ␣4-helix, and ␣4/
␤6-loop (11–13), ␣2-helix, and ␣2/␤4-loop (14), ␣3/␤5-loop (15),
␣N/␤1-loop (13) and amino acids 110 –119 from the ␣-helical
domain (16) are involved in receptor-coupling selectivity. Some
of these domains contact the receptor directly, while others
regulate receptor-coupling selectivity indirectly by playing a
role in nucleotide exchange. Despite the fact that many of the
receptor-interacting domains have been identified, the relationship between receptor subtypes and G␣ domains involved
in receptor coupling has not been clearly established. Thus, it is
difficult to predict which G␣ domains will be utilized by a
specific receptor. Here we propose that individual receptors
recognize specific patterns formed by amino acids of G␣ thus
making G-protein interface look different for different receptors. The C terminus of G␣ is a well accepted receptor recognition domain, which contacts receptors directly (17). Although
individual C-terminal amino acids important for receptor coupling have been identified in several G␣ subunits, the specific
G␣ amino acids participating in receptor recognition may differ
among receptors. The ␣4-helix-␣4/␤6-loop domain, first described as an effector domain, has been shown to be important
for 5-HT1B receptor coupling to Gi1 (11). Later it was demonstrated that Gln-304 and Glu-308 in the ␣4-helix of Gi1␣ are
important for 5-HT1B receptor coupling (18). However the generality of the role for the ␣4-helix-␣4/␤6-loop domain in receptor coupling selectivity has not been determined.
Gi1␣ and Gt␣ are closely related G␣ subunits, which belong to
the Gi/o class of G-protein ␣-subunits, share 68% homology, and
have nearly identical overall structures. Although the 5-HT1B
receptor discriminates between Gi1 and Gt (11, 19), the fact
that their C termini are identical render Gi1␣/Gt␣ chimeras
useless for exploring the role of this domain in receptor coupling. However, the extreme C terminus of Gq␣ differs from
that of Gi1␣ by four amino acids, while their ␣5-helices differ by
an additional nine amino acids. Thus Gi1␣/Gq␣ chimeras are
ideal for studying the role of this domain in coupling. Since
several different GPCRs can couple to the same G-protein, we
wanted to test the hypothesis that individual receptors utilize
slightly different domains on G␣ subunits to achieve coupling.
G-protein receptor coupling selectivity may also be regulated at
the level of G-protein concentration. In fact, Clawges et al. (20)
demonstrated that 5-HT1A and 5-HT1B receptors distinguish
themselves by the affinity with which they interact with Gproteins. Therefore we also wanted to test the generality of this
mechanism with different receptors. Here we compare the coupling behavior of four Gi/o-coupled receptors (5-HT1A and
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5-HT1B serotonin, A1 adenosine and M2 muscarinic) by reconstituting them with G-protein heterotrimers containing native
or chimeric G␣ subunits composed of G␣i1, G␣t, and G␣q. Our
data demonstrate that selective coupling between Gi1 and the
members of Gi/o-coupled receptor family is directed by multiple
and distinct G␣ domains and is regulated at the level of Gprotein concentration.
EXPERIMENTAL PROCEDURES

Materials—[3H]Oxotremorine-M acetate ([3H]OXO-M) (85.8 Ci/
mmol), [3H]hydroxytryptamine binoxalate (5-[3H]HT) (25.5 Ci/mmol),
and chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA) (30 Ci/mmol) were
from PerkinElmer Life Science Products, Inc. (Boston, MA). Atropine
sulfate, 5-hydroxytryptamine (5-HT) and R-phenylisopropyl adenosine
(R-PIA) were from Sigma-Aldrich Corporation. Adenosine deaminase
was from Roche Applied Science (Indianapolis, IN). The BCA protein
Assay reagents were from Pierce. All other chemicals were from SigmaAldrich Corporation or EMD Biosciences (formerly Calbiochem-Novabiochem Corporation; San Diego, CA).
Expression and Purification of Proteins—The expression and purification of the G␣i1 and G␤␥ subunits was as previously described (21, 22).
The chimeric G␣i1/G␣t subunits were constructed, expressed in Escherichia coli and purified as described (19). The Gi1/Q3C, Gi1/Q5C, and
Gi1/Q11C chimeras (which have the 3, 5, or 11 C-terminal residues of Gi1␣
replaced with those from Gq␣) were made from pHis6G␣i1 using the silent
BamHI site introduced at amino acid position 212 (19). The pHis6G␣i1
cDNA was amplified by PCR reaction with primer oligonucleotides containing the desired mutations. The PCR products were digested with
BamHI and HindIII, and the BamHI-HindIII fragment was used to replace the corresponding fragment from pHis6G␣i1. To construct Gi1/Q35C
(which has the 35 C-terminal residues of Gi1␣ replaced with those from
Gq␣), the C-terminal portion of a Gq␣ cDNA was amplified by PCR
reaction, followed by digestion with BglII and HindIII. The digested PCR
fragment was inserted into the BglII and HindIII sites of the Chi13
plasmid (11). Functional characterization of all bacterial subunits included GTP␥S binding, AlF4⫺-dependent conformational change (measured as an increase in intrinsic tryptophan fluorescence) or binding to the
cGMP phosphodiesterase ␥-subunit (11, 18, 19).
Preparation of Sf9 Membranes Containing Expressed Receptors—Sf9
cells were infected with a recombinant baculovirus expressing the desired receptor, cultured, and harvested as previously described (22). To
prepare membranes, harvested cells were thawed in 15⫻ their wet
weight of ice-cold homogenization buffer (10 mM Tris-Cl, pH 8.0 at 4 °C,
25 mM NaCl, 10 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride, 20 g/ml of benzamidine, and 2 g/ml of
each of aprotinin, leupeptin, and pepstatin A) and burst by nitrogen
cavitation (600 psi, 20 min). Cavitated cells were centrifuged at 4 °C for
10 min at 500 ⫻ g to remove the unbroken nuclei and cell debris. The
supernatant from the low speed spin was centrifuged at 4 °C for 30 min
at 28,000 ⫻ g. The supernatant was discarded, and the pellets were
resuspended and pooled in 35 ml of HE buffer (5 mM NaHEPES, l mM
EDTA, pH 7.5) containing the same protease inhibitors as used in the
homogenization buffer. Adenosine receptor HE buffer included 100 mM
NaCl in addition to the above components. The membranes were
washed twice in HE, resuspended in the same buffer at a concentration
of 1–3 mg protein/ml, aliquoted, snap frozen in liquid nitrogen, and
stored at ⫺70 °C.
Reconstitution of Receptors with Exogenous G-proteins—Frozen
membranes were thawed, pelleted in a refrigerated microcentrifuge (10
min, 12,000 rpm), and resuspended at about 10 mg/ml in a reconstitution buffer consisting of 5 mM NaHEPES, 100 mM NaCl, 5 mM MgCl2, 1
mM EDTA, 500 nM GDP, 0.04% CHAPS (0.08% CHAPS for M2 receptor), pH 7.5. G-protein subunits were diluted in the same buffer such
that the desired amount of subunit was contained in 1–5 l. Typically,
1–2 l of G-protein subunits were added to 40 l of membrane suspension, the mixture was incubated at 25 °C for 15 min and held on ice until
the start of the binding assay.
Radioligand Binding—Just prior to the start of the binding assay the
reconstitution mixture was diluted 10 –12-fold with binding assay
buffer appropriate to the receptor of interest such that the desired
amount of membranes (5–25 g/assay tube) were contained in 10 –50 l.
Binding buffer for 5-HT and M2 receptors was 50 mM Tris, 5 mM MgCl2,
0.5 mM EDTA, pH 7.5. Binding buffer for A1 adenosine receptor was 10
mM HEPES, 5 mM MgCl2, 1 mM EDTA, pH 7.4. Radioligand binding in
the affinity shift assay was determined in the presence of the [3H]OXOM for M2 muscarinic receptor, 5-[3H]HT for 5-HT serotonin receptors
and [3H]CCPA for A1 adenosine receptor. Adenosine deaminase was
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added to the [3H]CCPA solution at 12 g/ml in binding buffer. Nonspecific binding was determined by addition of 1000-fold excess of unlabeled ligand, 5-HT for 5-HT receptors, atropine sulfate for M2 receptor
and R-PIA for A1 receptor. Incubations were for times sufficient to
achieve equilibrium in a temperature controlled shaker (1 h for M2
receptor, 1.5 h for 5-HT receptors, 2 h for A1 receptor) and were
terminated by filtration over Whatman GF/C filters using a Brandel
Cell Harvester. The filters were rinsed thrice with 4 ml of ice-cold 50
mM Tris-Cl, 5 mM MgCl2, 0.5 mM EDTA, 0.01% sodium azide, pH 7.5 at
4 °C, placed in 4.5 ml of CytoScint (ICN Pharmaceuticals, Costa Mesa,
CA) and counted to constant error in a scintillation counter. For reconstitution of high affinity agonist binding in affinity shift assays, a single
concentration of radioligand near the high affinity KD of the receptor of
interest was used in a final volume of 150 l. [3H]-5-HT radioligand
purity was monitored by HPLC or TLC using an appropriate mobile
phase. Radioligands were repurified or replaced when the radiochemical purity fell below 85%.
Affinity Shift Activity Assay—The Sf9 cell membranes expressing
individual receptors were reconstituted with saturating amounts of
native or chimeric Gi1 protein heterotrimers (ⱖ25 nM or 40 – 400-fold
molar excess over receptors) to achieve the maximal specific binding
during the binding assays. Because the magnitude of the affinity shifts
observed with native Gi1 protein heterotrimers varied significantly
among the individual receptors affinity shift activity was normalized to
Gi1 activity and expressed as percent affinity shift activity, which is
(Chimera Reconstituted Binding ⫺ Control Binding/Gil Reconstituted
Binding ⫺ Control Binding) ⫻ 100.
Analysis of Data—Data analysis was done using the GraphPad
Prism software package (GraphPad Software, San Diego, CA). For
affinity shift assays, triplicate determinations were used within each
experiment, and experiments were repeated three or more times. Data
represent the mean ⫾ S.E. from multiple experiments. One-way analysis of variance with Tukey’s multiple comparison post-test was used to
compare the activities of chimeras.
RESULTS

Previously we have shown that amino acids 299 –318 and
1–219 of Gi1␣ are molecular determinants of 5-HT1B receptor
coupling (11) and that two amino acids in the ␣4-helix of Gi1␣
(Gln-304 and Glu-308) are especially important for 5-HT1B
receptor coupling (18). The goal of the present study was to
examine the generality of these findings among closely related
members of the Gi/o-coupled receptor family. Our general strategy involves reconstitution of purified G-proteins containing
chimeric ␣-subunits with receptors expressed in Sf9 insect cell
membranes and comparison of the abilities of these chimeric
G-proteins to stabilize the high affinity agonist binding state of
the receptors in an affinity shift activity assay. In the present
study we compared the coupling behavior of four different
Gi/o-coupled receptors: 5-HT1A and 5-HT1B serotonin receptors,
M2 muscarinic receptors, and A1 adenosine receptors.
Affinities of Individual Receptors for G-proteins—First we
determined the concentration of G-proteins in the binding assay that produced the maximum affinity shift for each receptor.
Increasing amounts of G-protein heterotrimers were reconstituted with individual receptors and EC50 values for reconstitution of high affinity agonist binding were determined. The
data indicate that A1, 5-HT1A, 5-HT1B, and M2 receptors have
different EC50 values for Gi1 (Fig. 1). A1 receptors have the
highest apparent affinity (0.4 nM) and M2 receptors have the
lowest apparent affinity (47 nM) for the Gi1 heterotrimer. 5-HT
receptors have intermediate EC50 values of 3.7 and 16.2 nM for
the 5-HT1A and 5-HT1B receptors, respectively. Titration experiments similar to those shown in Fig. 1 were used to determine the concentration of chimeric G-proteins needed to saturate affinity shift activities with individual receptors. In
agreement with earlier studies (11, 18, 20), the EC50 values of
the active G-proteins were not significantly different for individual receptors, and even high concentrations (⬎600 nM) of
inactive chimeras did not have affinity shift activity (data not
shown). All affinity shift activities were determined with saturating concentrations of G-proteins.
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Affinity Shift Activity of Chimeric G␣ Subunits—Fig. 2 depicts the secondary structures of the Gi1␣/Gt␣ chimeras used in
this study. All of these chimeras have been previously described and were used to study Gi1␣ domains involved in
5-HT1B receptor coupling (11, 18, 19). Fig. 3, in which 100%
activity corresponds to the affinity shift activity of Gi1, shows
the percent affinity shift activity of Chi2, Chi3, Chi6, Chi13,
and Chi21. Chi6 was constructed as a soluble analog of Gt␣ and
has the same functional properties as Gt␣ (19). Chi6 is primarily Gt␣ in character as it includes N-terminal amino acids
1–215 and C-terminal amino acids 295–350 of Gt␣ with the
amino acids corresponding to 216 –294 from Gi1␣ to maintain
solubility. In this region there are just 26 amino acids that
differ between Chi6 and Gt␣. As shown in Fig. 3, Chi6 was
inactive with 5-HT1A, 5-HT1B, and M2 muscarinic receptors.
Earlier experiments with native transducin demonstrated it
also failed to couple with the 5-HT receptors (20). In contrast,

FIG. 1. Concentration dependence of Gi1 in affinity shift assays
for individual Gi1-coupled receptors. Sf9 cell membranes expressing the indicated Gi1-coupled receptors were reconstituted with increasing concentrations of Gi1 heterotrimer. The affinity shift activities for
each receptor were normalized and fit to a single site interaction between receptor and G-protein. The magnitude of the affinity shift activity (-fold enhancement of agonist binding above non-reconstituted
controls) with saturating amounts of Gi1 was 4.1 ⫾ 0.51, n ⫽ 17, for the
5-HT1A receptor; 3.8 ⫾ 0.19, n ⫽ 22, for the 5-HT1B receptor, 4.4 ⫾ 0.37,
n ⫽ 17, for the A1 receptor; and 12.2 ⫾ 1.04, n ⫽ 35, for the M2 receptor.
Saturation was achieved for each receptor, however for visual purposes
the curves have been extended to a common end point. Shown are the
data from representative experiments. EC50 data are the mean ⫾ S.E.
from three or more independent experiments.

FIG. 2. Secondary structure of G␣
subunits. Numbers above the chimeric
structures indicate the junction points of
G␣t and G␣i1 sequences and refer to the
amino acid positions in G␣t. Numbers for
the wild-type forms of G␣t and G␣i1 represent their total amino acid residues.
The bottom diagram depicts the secondary structural domains common to G␣
subunits.

the data in Fig. 3 demonstrate Chi6 was 74% active with the A1
adenosine receptor, indicating that A1 adenosine receptor does
not discriminate well between Gt and Gi1 sequences. Similarly,
native transducin was 80% active with the A1 adenosine receptor, which is not significantly different from Chi6 (data not
shown). Although the activity of Chi6 (and native transducin)
with the A1 adenosine receptor was significantly lower (p ⬍
0.001) than the activity of Gi1, the magnitude of the difference
was too small to be of use in identifying the precise domains
responsible for the reduced activity. However, the inability of
the 5-HT1A, 5-HT1B, and M2 muscarinic receptors to couple
with Chi6 allowed us to use additional chimeras containing less
Gt␣ sequence to more precisely identify the domains required
for coupling.
We first examined whether the N-terminal or C-terminal
portion of Gi1␣ was critical for receptor coupling. Chi21 has
N-terminal amino acids 1–215 of Gt␣ with the rest of the
molecule Gi1␣ sequence (Fig. 2). Chi21 was fully active with the
A1 adenosine receptor, indicating that the A1 receptor does not
distinguish between N-terminal amino acid sequences of Gi1␣
and Gt␣ (Fig. 3). The activity of Chi21 with 5-HT1A, 5-HT1B,
and M2 receptors was significantly (p ⬍ 0.001) reduced (44, 57,
and 42% respectively, Fig. 3) demonstrating that amino acids
1–219 of Gi1␣ contain an important determinant of Gi coupling
with these receptors. Chi2 has the C-terminal amino acids
295–350 of Gt␣ with the rest of the chimera Gi1␣ sequence (Fig.
2). Fig. 3 demonstrates that amino acids 299 –354 of Gi1␣
contain residues critical for 5-HT1A, 5-HT1B, and M2 receptor
coupling because the affinity shift activity of Chi2 with these
receptors (2, 9, and 23% respectively) was not significantly
different from Chi6 activity. In contrast, Chi2 was fully active
with A1 adenosine receptors supporting our conclusion that A1
adenosine receptor does not distinguish well between Gi1␣ and
Gt␣ sequences. To further evaluate the role of amino acids
299 –354 of Gi1␣ in 5-HT and M2 receptor coupling we tested
two additional chimeras, Chi3 and Chi13 (Fig. 2). Chi3 has
amino acids 299 –319 of Gi1␣ replaced with the corresponding
amino acids of Gt␣ (amino acids 295–315) while Chi13 has the
35 C-terminal amino acids of Gi1␣ replaced with the corresponding amino acids of Gt␣. As shown in Fig. 3, the affinity
shift activities of Chi3 show that amino acids 299 –319 of Gi1␣
(␣4-helix and ␣4/␤6-loop) are critical for 5-HT1A, 5-HT1B, and
M2 receptor coupling, but not for A1 adenosine receptor coupling. In contrast, Chi13, with six amino acids variant from
Gi1␣, was active with all four receptors indicating that the 35
C-terminal amino acids of Gi1␣ and Gt␣ are functionally inter-
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FIG. 4. Primary sequence alignment of the ␣4-␣4/␤6-loop region of G␣i1 and G␣t. The boxes indicate the regions of G␣i1 that were
substituted with the corresponding sequences from G␣t to generate the
indicated G␣i1/G␣t chimeras.

FIG. 3. Functional coupling of receptors to the indicated Gi1/Gt
chimeras. Sf9 cell membranes expressing individual receptors were
reconstituted with the indicated chimeric G␣ and ␤␥ subunits. Data
represent the percent affinity shift activities as mean ⫾ S.E. from three
or more independent experiments for each receptor. Exogenous Gproteins were present in 40 –200-fold molar excess over receptors during reconstitution to achieve the maximal specific binding during the
binding assays.

changeable in coupling these receptors. Nevertheless, the significantly (p ⬍ 0.01) reduced activity of Chi13 (85.9%) with the
M2 receptor and the significantly (p ⬍ 0.01) increased activity
with both 5-HT1A (128%) and 5-HT1B (124.5%) receptors suggest subtle differences in the coupling mechanism of these
receptors. The role of the extreme C terminus of Gi1␣ cannot be
evaluated with these chimeras because the eight C-terminal
amino acids of Gi1␣ and Gt␣ are identical.
Role of the ␣4-Helix and ␣4/␤6-Loop of Gi1␣ in Receptor
Coupling—In order to investigate the ␣4-␣4/␤6 region of Gi1␣
in more detail we used several additional chimeras to subdivide
this region (Fig. 4). Chi22 has the ␣4-helix of Gi1␣ replaced with that from Gt␣ while Chi25 has the ␣4/␤6-loop of
Gi1␣ replaced with that from Gt␣. Chi23 has the ␣4/␤6-loop
of Gi1␣ replaced with that from Gt␣ and also switches the Glu
in Gi1␣ at the end of the ␣4-helix for the Leu found in Gt␣.
Chi24 has the central part of the ␣4/␤6-loop with two variant
amino acids switched between Gi1␣ and Gt␣. These chimeras
were fully active with the A1 adenosine receptor (data not
shown), supporting our conclusion that the A1 receptor does
not use the ␣4-␣4/␤6 region to distinguish between Gt and Gi1
(see Fig. 3). Fig. 5 shows the affinity shift activity of these
chimeras with 5-HT1A, 5-HT1B, and M2 receptors. Chi22 had
low affinity shift activity with all three receptors indicating
that a critical determinant of coupling selectivity for these
receptors is located in the ␣4-helix of Gi1␣ (Fig. 5). For the
5-HT1B receptor, the activity of Chi22 was significantly higher
than the activity of Chi3 (p ⬍ 0.01), indicating that the ␣4/␤6loop may also play a role in 5-HT1B receptor coupling. This
conclusion is supported by the Chi25 activity with the 5-HT1B
receptor (73%), which was significantly (p ⬍ 0.001) lower than
the activity of Gi1 (100%). However, Chi25 was 91% as active
with M2 muscarinic receptor) which was not significantly different (p ⬎ 0.05) from Gi1 activity) and was 121% as active with
the 5-HT1A receptor (which was significantly (p ⬍ 0.001) higher
than Gi1). Taken together the data suggest the ␣4/␤6-loop is
utilized differently by these receptors. Chi24 was fully active
with all three receptors (Fig. 5), which suggests that the reduced activity of Chi25 with the 5-HT1B receptor is due to the
replacement of Asp-309 by Glu at the beginning of the ␣4/␤6loop (Fig. 4). Fig. 5 also shows the affinity shift activity of Chi23
was significantly reduced (p ⬍ 0.001) compared with the activity of both Gi1 and Chi25 for all three receptors. Chi23 differs

FIG. 5. Functional coupling of receptors to the indicated Gi1/Gt
chimeras. Sf9 cell membranes expressing individual receptors were
reconstituted with the indicated chimeric G␣ and ␤␥ subunits. Data
represent the percent affinity shift activities as mean ⫾ S.E. from three
or more independent experiments for each receptor. Exogenous Gproteins were present in 40 –200-fold molar excess over receptors during reconstitution to achieve the maximal specific binding during the
binding assays.

from Chi25 by just one amino acid (replacement of Glu-308
from Gi1␣ for Leu from Gt␣) indicating that Glu-308 is important for coupling to 5-HT1A, 5-HT1B, and M2 receptors. Taken
together, the data indicate that the ␣4-helix (Glu-308 in particular) is important for all three receptors, and that the ␣4/
␤6-loop (probably Asp-309) is also important for 5-HT1B
receptors.
Defining Individual Amino Acids in the ␣4-␣4/␤6 Region of
Gi1␣—To prove the role of Glu-308 in receptor coupling and
also to study the role of other amino acids in the ␣4-␣4/␤6
region of Gi1␣ we used chimeras in which amino acids Ala-301,
Gln-304, Cys-305, Glu-308, Lys-312, and Thr-316 of Gi1␣ were
replaced individually or in combinations with the corresponding amino acids of Gt␣. All of the mutants used here have been
previously described (18). First we studied the role of these
amino acids with a loss of function assay. Mutants in which
amino acids of Gi1␣ were replaced individually or in combinations with the corresponding amino acids of Gt␣ would be
expected to exhibit reduced affinity shift activities if these
amino acids were important for coupling. Replacement of Ala301 with Asn did not reduce activity (Gi1A301N, Fig. 6) demonstrating that Ala-301 is not important for coupling any of the
receptors tested. When Gln-304 was changed to Lys
(Gi1Q304K, Fig. 6) activity with 5-HT1A and M2 receptors was
significantly (p ⬍ 0.001) reduced, but as reported previously
(18), this single amino acid replacement did not significantly
reduce affinity shift activity with 5-HT1B receptors (Fig. 6). The
activity of Gi1C305V shows that Cys-305 is important for M2
muscarinic receptors (67% activity, p ⬍ 0.001) but not important for either 5-HT receptor (Fig. 6). Glu-308 is an important
amino acid for all three receptors as the Gi1E308L mutant
displays 62, 73, and 61% of activity with 5-HT1A, 5-HT1B, and
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FIG. 6. Functional coupling of receptors to the indicated Gi1␣
point mutants. Sf9 cell membranes expressing individual receptors
were reconstituted with the indicated chimeric G␣ and ␤␥ subunits.
Data represent the percent affinity shift activities as mean ⫾ S.E. from
three or more independent experiments for each receptor. Exogenous
G-proteins were present in 40 –200-fold molar excess over receptors
during reconstitution to achieve the maximal specific binding during
the binding assays.

M2 receptors, respectively (p ⬍ 0.001) (Fig. 6). Lys-312 and
Thr-316 are not important for coupling these receptors and the
increased activity of Gi1K312M and Gi1T316V with the 5-HT1A
receptor (p ⬍ 0.001) is consistent with the increased activity of
Chi25 with this receptor.
Data obtained with three double mutants (Gi1Q304K/C305V,
Gi1Q304K/E308L, Gi1C305V/E308L) and a triple mutant
(Gi1Q304K/C305V/E308V) support the conclusions drawn from
the point mutants (Fig. 6). The activity of the Gi1Q304K/E308L
mutant was lower than the activity of either Gi1Q304K or
Gi1E308L for all receptors supporting the importance of both
Gln-304 and Glu-308 in receptor coupling. The role of Cys-305
in M2 receptor coupling is supported by the observation that
the activity of Gi1Q304K/C305V mutant was significantly lower
than the activity of the Gi1Q304K mutant (p ⬍ 0.05). Furthermore, the activity of the triple mutant (Gi1Q304K/C305V/
E308V) was the lowest of all with the M2 receptor, supporting
the idea that Gln-304, Cys-305, and Glu-308 are all important
for M2 receptor coupling. On the other hand, the conclusion
that Cys-305 is not important for coupling the 5-HT1A and
5-HT1B receptors is supported by the observations that the
304/305 and 305/308 double mutants have similar activities
with these receptors as the Q304K and E308L single mutants
and the 304/305/308 triple mutant is similar in activity to the
304/308 double mutant with these receptors.
Gain of function assays, in which amino acids from Gi1␣
replaced those from Gt␣ in Chi22 were used to confirm the role
of the amino acids identified in the loss of function assay. The
data in Fig. 7 demonstrate that substituting back Ala-301 does
not lead to gain of function with any of the receptors tested,
supporting the conclusion that Ala-301 of Gi1␣ is not important
for receptor coupling. Substituting back Gln-304 (Chi22K300Q)
resulted in significant (p ⬍ 0.001) gain of activity with 5-HT1B
receptors, which is in contrast to the absence of a loss of activity
with 5-HT1B receptors when Gln-304 was mutated to Lys in
Gi1␣. Similarly, substituting back Cys-305 in the Chi22V301C
mutant resulted in significant (p ⬍ 0.05) gain of activity with
5-HT1B receptors but had no effect with M2 receptors. The
precise reasons for these anomalies are unknown but may

FIG. 7. Functional coupling of receptors to the indicated Chi22
point mutants. Sf9 cell membranes expressing individual receptors
were reconstituted with the indicated chimeric G␣ and ␤␥ subunits.
Data represent the percent affinity shift activities as mean ⫾ S.E. from
three or more independent experiments for each receptor. Exogenous
G-proteins were present in 40 –200-fold molar excess over receptors
during reconstitution to achieve the maximal specific binding during
the binding assays.

be related to the actual role of these amino acids in the context of their neighbors. Substituting back Glu-308 alone
(Chi22L304E) resulted in a gain of affinity shift activity of 48%
with 5-HT1A receptors (p ⬍ 0.001), 38% with 5-HT1B receptor
(p ⬍ 0.001) but only 17% (p ⬎ 0.05) with M2 receptors. However, when both Gln-304 and Glu-308 were substituted back
into Chi22 sequence (Chi22K300Q/L304E), a full gain of activity was observed with 5-HT1A and 5-HT1B receptors, as
Chi22K300Q/L304E activity was not significantly different
from activity of Gi1 (100%). The gain of function with M2
receptors was significant (45% gain of activity, p ⬍ 0.001),
though still less than the activity of Gi1. Taken together, the
data indicate that Gln-304 and Glu-308 of Gi1␣ are important
for 5-HT1A, 5-HT1B, and M2 receptor coupling, and that Cys305 of Gi1␣ is important for M2 receptor coupling in addition to
Gln-304 and Glu-308.
Role of C Terminus of Gi1␣ in Receptor Coupling—Alignment
of the C-terminal sequences of Gi1␣ and Gt␣ indicates that their
extreme eight C-terminal amino acids are identical (Fig. 8).
Because numerous studies have indicated the C terminus of G␣
plays a significant role in receptor coupling, we decided to
investigate the role of C terminus of Gi1␣ in 5-HT1A, 5-HT1B,
A1, and M2 receptor coupling using Gi1␣/Gq␣ C-terminal chimeras in which 3, 5, 11, or 35 C-terminal residues of Gi1␣ were
replaced with those from Gq␣. These chimeras are designated
Q3C, Q5C, Q11C, and Q35C, respectively. As shown in the
sequence alignments in Fig. 8, the extreme C terminus of Gq␣
differs from that of Gi1␣ in just four amino acids. Loss of
function experiments may demonstrate partial or complete loss
of activity. As shown in Fig. 9, replacement of just two of these
amino acids with those from Gq␣ in the Q3C mutant significantly lowers the affinity shift activity with all four receptors.
The nearly complete loss of affinity shift activity (0.3 and
11.2%, respectively) with 5-HT1B serotonin and A1 adenosine
receptors suggests that these amino acids are critical for coupling, while the more modest decrease in activity (65 and 68%
activity, respectively) with the 5-HT1A and M2 receptors sug-
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FIG. 8. Sequence alignment of 35 C-terminal amino acids of Gt␣, Gi1␣ and Gq␣. The sequences of Gt␣ and Gq␣ are compared with Gi1␣
sequence. Depicted in bold are amino acids of Gt␣ and Gq␣ that are different from corresponding amino acids of Gi1␣.

FIG. 9. Functional coupling of receptors to the indicated
Gi1/Gq chimeras. Sf9 cell membranes expressing individual receptors
were reconstituted with the indicated chimeric G␣ and ␤␥ subunits.
Data represent the percent affinity shift activities as mean ⫾ S.E. from
three or more independent experiments for each receptor. Exogenous
G-proteins were present in 40 – 400-fold molar excess over receptors
during reconstitution to achieve the maximal specific binding during
the binding assays.

gest these amino acids are important, but not critical, for coupling. Substitution of the five C-terminal amino acids of Gi1␣
with those from Gq␣ eliminates coupling with the A1 adenosine
receptor while substitution of 11 C-terminal amino acids are
required for complete loss of 5-HT1A receptor coupling (Fig. 9).
These data indicate that the 5-HT1A, 5-HT1B, A1 adenosine,
and M2 muscarinic receptors differ in their utilization of the
C-terminal amino acids of Gi1␣ for coupling.
DISCUSSION

G-protein receptor coupling can be regulated by a variety of
mechanisms (2, 3). At the G-protein-receptor interface, the
selectivity of coupling is regulated by the amino acid sequences
of both receptor and G-protein. By comparing the coupling
mechanism of four closely related receptors to the same Gproteins, we found that receptors use multiple and distinct
domains on G␣ to achieve selective coupling. Coupling selectivity is also regulated by the G-protein concentration as demonstrated by the significant differences among the EC50 values
for Gi1 receptor interactions. This suggests that in living cells
the expression levels of specific G-protein subunits may regulate receptor-coupling preferences.
At the level of G␣ domains, the major difference we found is
that the A1 adenosine receptor does not discriminate well between Gi1␣ and Gt␣ sequences. In contrast, the 5-HT and M2
receptors couple with Gi1 but fail to couple with Gt. This selectivity allowed us to use Gi1␣/Gt␣ chimeras to define domains on
Gi1␣ important for coupling with these receptors. Our findings
indicate that amino acids especially important for receptor coupling are located in the ␣4-helix. In addition, the 5-HT1B receptor
may require Asp-309 at the beginning of ␣4/␤6-loop for optimal
coupling. The corresponding amino acid in Gt␣ is Glu-305, and
while both are negatively charged, glutamate is one -CH2 group
bigger than aspartate. Thus replacement of aspartate with glutamate may decrease 5-HT1B receptor coupling because of the
change in the size of the receptor interacting surface on G␣. In

addition, we demonstrated that within the ␣4-helix-␣4/␤6-loop
region of Gi1␣ the amino acids that are involved in receptor
coupling differ slightly among the receptors. While all three receptors utilize Gln-304 and Glu-308, the M2 receptor also uses
Cys-305 and the 5-HT1B receptor may use Asp-309. Interestingly,
interaction of the 5-HT1A receptor with the K312M mutant actually leads to an increased affinity shift. This increase in affinity
shift activity may represent tighter coupling of the receptor with
the chimera. Other investigators have also demonstrated the
importance of this region of G␣ in receptor coupling. Natochin et
al. (12) demonstrated the role of Arg-310 and Asp-311 in interaction of Gt␣ with rhodopsin. Blahos et al. (13) demonstrated that
␣4-␣4/␤6-␤6-␣5 region of G␣16 is important but not critical for
interaction with metabotropic glutamate receptor 8. In contrast,
the work of Grishina and Berlot (15) shows that the ␣4/␤6-loop of
G␣s is not important for interactions with ␤2 adrenergic receptors. Using gain of function experiments, Ho and Wong (23)
demonstrated that incorporation of ␣4/␤6-loop of G␣z into a G␣t
backbone was not sufficient for ␦-opioid receptor coupling. Taken
together, these results support the idea that even if different
receptors recognize the same general domain on G␣ subunits, the
specific amino acids involved in receptor interactions may be
different.
Another region of Gi1␣ important for 5-HT and M2 receptor
coupling is the N terminus, as affinity shift activity with Chi21
was lower than with Gi1 for these receptors. According to the
literature, the amino acids that bind to the receptor map to
approximately positions 1–30 of the ␣-subunits (4). This region,
which includes the N terminus and the ␣N-helix, contains the
most differences between Gi1␣ and Gt␣ with 15 variant amino
acids compared with just 9 variants from amino acids 31 to 219.
Another significant difference between Gi1␣ and Gt␣ is that the
␣N-helix of Gt␣ is 4 amino acids shorter than the ␣N-helix of
Gi1␣. Thus it is possible that amino acids 1–30 are important
but not critical for 5-HT and M2 receptor coupling.
Although the C terminus of G␣ subunits is postulated to
directly contact the receptor and mediate receptor coupling
selectivity, our data show that the specific amino acids involved
in this recognition differ among the receptors studied. Cys-351
(position-4), Gly-352 (position-3), and Phe-354 (position-1) in Gi
family members have been shown to be important for mediating selectivity of receptor coupling (reviewed in Ref. 2). Gain of
function studies with Gq/i chimeras (5, 24) indicate that five
C-terminal amino acids of Gi␣ are sufficient for coupling to A1
and M2 receptors while three C-terminal amino acids of Gi␣ are
not enough for A1 receptor coupling (5). Although so far it has
not been possible to successfully solve the structure of the G␣ C
terminus in the context of the whole molecule (the C terminus
is disordered in the crystal), the structure of the C-terminal
undecapeptide of Gt␣ bound to activated rhodopsin has been
resolved by NMR spectroscopy (25). In this C- terminal decapeptide, the first eight residues form an ␣-helix, which is
terminated by an ␣L type C-cap (26) with C-terminal glycine
(Gly-348 in Gt␣, Gly-352 in Gi1␣) in the center of the reverse
turn (27). Thus the observation (5) that for the A1 receptor
three C-terminal amino acids of Gi1␣ are critical in the loss of
function experiments but five C-terminal amino acids are re-
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FIG. 10. Receptor recognition surfaces on Gi1␣. The images of
the molecular surfaces were generated using SPOCK (29) with coordinates from the crystal structure of the heterotrimer solved by Wall et al.
(28). The six C-terminal residues of Gi1␣ are not present in the crystal
structure of the trimer and are represented here by the NMR structure
of the Gt␣ C-terminal peptide (27) that has been docked to the crystal
structure. The ␣-subunit is shown in blue and the ␤␥-subunit in gray.
The four panels represent the G-protein surfaces required for functional
coupling with the indicated receptors. The regions of Gi1␣ colored red
and yellow (red only for the C termini of the A1 and 5-HT1B receptors)
eliminated receptor coupling upon replacement with the corresponding
regions from Gt␣ or Gq␣ and are termed critical. Within these critical
regions the residues colored yellow reduced coupling when tested alone
and are termed important. Regions colored green also reduced coupling
upon replacement and are termed important but were not found to be
part of a larger region that eliminated coupling.

quired to gain coupling may be explained by the fact that this
␣L C-cap, which is disrupted in Gi1/Q3C chimera, is required for
A1 receptor coupling. This is probably also true for the 5-HT1B
receptor. Our M2 receptor data indicate that although this ␣L
C-cap structure is important, it is not critical for receptor
coupling. For the 5-HT1A receptor three C-terminal amino acids of Gi1␣ are important while amino acids at the positions ⫺4
and ⫺5 (Asp-350 and Cys-351) are not important since the
activities of Gi1/Q3C and Gi1/Q5C are the same. Gi/Q5C and
Gi/Q11C are different in three amino acids, which are probably
involved in 5-HT1A receptor coupling. Some additional amino
acids involved in 5-HT1A receptor coupling are located in the
␣5-helix (see Fig. 8) as evident from the activity of Gi1/Q35C
chimera. Taken together, our results support the idea that
different receptors may recognize a specific pattern of amino
acids, which form receptor recognition surfaces.
Fig. 10 depicts a structure of the G␣i1␤1␥2 G-protein heterotrimer. Six amino acids from the C terminus and four amino
acids from the N terminus are missing from the crystal structure of the heterotrimer solved by Wall et al. (28) and so the
C-terminal residues from the NMR structure of the Gt␣ Cterminal decapeptide (27) have been docked to the crystal
structure. The domains of Gi1␣ discussed herein are surface
exposed and located on the G-protein surface that is presumed
to face the receptor. They are therefore available for receptor
coupling. However, while some amino acids may be involved in
coupling by making direct contact with receptors, others may
be involved indirectly by playing a role in guanine nucleotide
exchange, and it is not possible to distinguish between these
possibilities based on our functional coupling assays. Regions of
Gi1␣ that eliminated coupling upon replacement with the corresponding regions from Gt␣ or Gq␣ have been colored red and
yellow in Fig. 10, with the yellow portions defining residues
whose replacement merely reduced coupling. The green regions
also merely reduced coupling but were not found to be part of a

larger region that eliminated coupling. Clearly the regions
responsible for coupling the individual receptors are subtly
different. The adenosine A1 and 5-HT1B receptors are sensitive
to a very small (just two amino acids) change in the extreme C
terminus, while the M2 muscarinic and 5-HT1A receptors use a
larger portion of the C terminus to distinguish among the G␣
subunits. Furthermore, slightly different residues within the
␣4-helix are used by the 5-HT1A, 5-HT1B, and M2 muscarinic
receptors while this region is not used by A1 adenosine receptors. Amino acids Glu-304, Cys-305, Glu-308, and Asp-309 are
surface-exposed and so are available for receptor coupling.
Molecular modeling indicates that Gi1Q304K, Gi1E308L, and
Gi1304/308 mutations alter the surface potential (18), while the
Gi1D309E mutation alters steric interactions because Glu is
one CH2 group larger then Asp (water-accessible surfaces of
native Gi1 and Gi1D309E were constructed and superimposed
in Insight II; not shown). Therefore, structural considerations
are consistent with a role for these residues in receptor coupling. Similarly, the N terminus is used by the 5-HT1A, 5-HT1B,
and M2 muscarinic receptors (colored green in Fig. 10), but not
the A1 adenosine receptor. In summary, we have demonstrated
that four closely related Gi/o-coupled receptors distinguish
themselves by the affinity with which they interact with Gi1
and by their use of multiple and distinct domains of Gi1␣ for
selective coupling.
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